Diabetes complications

High incidence of low interstitial fluid glucose among type 2 diabetes patients with chronic kidney disease (CKD) despite adhering to appropriate glycated haemoglobin targets—has time come for robust integration of interstitial fluid glucose targets into glycaemic guidelines?

Diabet MedPublished Cross-sectional study

Authors' conclusion

The CKD cohort has a greater burden of hypoglycaemia despite being treated to similar HbA1c targets. The greater number of nocturnal events warrants safety concern. Interstitial fluid glucose targets should be incorporated into the glycaemic guidelines for T2D patients with CKD.

Study context

Population
T2D subjects with and without CKD recruited from a tertiary-care hospital
Participants
134 subjects
Exposure
T2D with CKD vs T2D without CKD
  • CKDn = 74
  • Non-CKDn = 60reference
Outcome
Burden of Level 1 (<4 mmol/L) and Level 2 (<3 mmol/L) hypoglycaemia
Follow-up
2 weeks sensor wear
Methodological detailssingle-centre, tertiary-care hospital, 2-week CGM (Freestyle Libre-Pro)
  • Single-centre
  • Tertiary-care hospital
  • 2-week CGM (Freestyle Libre-Pro)

Main finding

As reported in the abstract

2 weeks

Odds ratio

1.73

P = 0.011

Level 1 (<4 mmol/L) hypoglycaemia

Odds ratio

2.16

P = 0.002

Level 2 (<3 mmol/L) hypoglycaemia

Observational data: associations, not effects.

Further findings

HbA1c · no difference

P = 0.529

Glycaemic variability · 2 weeks

Level 2 hypoglycaemia events, nocturnal vs day, within CKD cohort · 2-week sensor wear · CKD cohort: 1.9 ± 3.1 vs 1.4 ± 2.5 events/person
P = 0.022

Glycaemic variability · 2 weeks

Increased glycaemic variability in CKD vs non-CKD

Level 2 hypoglycaemia events, nocturnal vs day, within CKD cohort · 2-week sensor wear

No significant intra-day difference in Level 2 events within non-CKD cohort

Original publication

High incidence of low interstitial fluid glucose among type 2 diabetes patients with chronic kidney disease (CKD) despite adhering to appropriate glycated haemoglobin targets—has time come for robust integration of interstitial fluid glucose targets into glycaemic guidelines? Diabet Med. Published 20 September 2024. doi:10.1111/dme.15438

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.